A Study to Evaluate the Benefit of Opti-Me Application to Different Treatments of MDD

NAUnknownINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

October 6, 2020

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Depressive Disorder, Major
Interventions
DIAGNOSTIC_TEST

Opti-Me

Opti-Me algorithm provides the likelihood of response to the 3 treatment options: SSRIs, SNRIs or TMS in MDD patients.

Trial Locations (2)

Unknown

RECRUITING

Beer Ya'aqov, Be’er Ya‘aqov

RECRUITING

University of Zurich Hospital, Zurich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ElMindA Ltd

INDUSTRY

NCT04148612 - A Study to Evaluate the Benefit of Opti-Me Application to Different Treatments of MDD | Biotech Hunter | Biotech Hunter